Use of exhaled nitric oxide measurement to identify a reactive, at-risk phenotype among patients with asthma.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  American Journal of Respiratory and Critical Care Medicine

• Publication date

  2010-05-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1164/rccm.200905-0695OCPMID 20133930PMCID PMC2874447
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice.

  2009cited by this paper
• Nitrative stress in refractory asthma.

  2008cited by this paper
• Exhaled nitric oxide predicts lung function decline in difficult-to-treat asthma

  2008cited by this paper
• Asthma phenotypes

  2007cited by this paper
• Fraction of exhaled nitric oxide at 50 mL/s: reference values for adult lifelong never-smokers.

  2007cited by this paper
• Genetic variation in S-nitrosoglutathione reductase (GSNOR) and childhood asthma.

  2007cited by this paper
• Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program.

  2007cited by this paper
• Severe asthma in adults: what are the important questions?

  2007cited by this paper
• Features of severe asthma in school-age children: Atopy and increased exhaled nitric oxide.

  2006cited by this paper
• Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations

  2006cited by this paper
• Asthma: defining of the persistent adult phenotypes.

  2006cited by this paper
• Standardisation of the measurement of lung volumes

  2005cited by this paper
• Protection from Experimental Asthma by an Endogenous Bronchodilator

  2005cited by this paper
• Correlation of systemic superoxide dismutase deficiency to airflow obstruction in asthma.

  2005cited by this paper
• Use of exhaled nitric oxide measurements to guide treatment in chronic asthma.

  2005cited by this paper
• ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005.

  2005cited by this paper
• Exhaled nitric oxide reflects asthma severity and asthma control

  2004cited by this paper
• "Refractory" eosinophilic airway inflammation in severe asthma: effect of parenteral corticosteroids.

  2004cited by this paper
• Phenotypes in asthma: useful guides for therapy, distinct biological processes, or both?

  2004cited by this paper
• Nitric oxide in health and disease of the respiratory system.

  2004cited by this paper
• Diagnosing asthma: comparisons between exhaled nitric oxide measurements and conventional tests.

  2004cited by this paper
• Acid stress in the pathology of asthma.

  2004cited by this paper
• Increased arginase II and decreased NO synthesis in endothelial cells of patients with pulmonary arterial hypertension

  2004cited by this paper
• The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma

  2003cited by this paper
• Airway Hyperresponsiveness: From Molecules to Bedside Selected Contribution: Temporal association of nitric oxide levels and airflow in asthma after whole lung allergen challenge

  2003cited by this paper
• Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial.

  2002cited by this paper
• NO chemical events in the human airway during the immediate and late antigen-induced asthmatic response

  2001cited by this paper
• Dose-response relationship and reproducibility of the fall in exhaled nitric oxide after inhaled beclomethasone dipropionate therapy in asthma patients.

  2001cited by this paper
• Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in children with difficult asthma, after treatment with oral prednisolone.

  2001cited by this paper
• Factors associated with persistent airflow limitation in severe asthma.

  2001cited by this paper
• A neuronal NO synthase (NOS1) gene polymorphism is associated with asthma.

  2000cited by this paper
• Airway nitric oxide diffusion in asthma: Role in pulmonary function and bronchial responsiveness.

  2000cited by this paper
• Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. American Thoracic Society.

  2000cited by this paper
• Exhaled nitric oxide in patients with asthma: association with NOS1 genotype.

  2000cited by this paper
• Rapid loss of superoxide dismutase activity during antigen-induced asthmatic response.

  2000cited by this paper
• Pathophysiology of severe asthma.

  2000cited by this paper
• Nitric oxide regulation of asthmatic airway inflammation with segmental allergen challenge.

  1999cited by this paper
• Effect of inhaled budesonide on lung function and airway inflammation. Assessment by various inflammatory markers in mild asthma.

  1999cited by this paper
• Lung function and sputum characteristics of patients with severe asthma during an induced exacerbation by double-blind steroid withdrawal.

  1999cited by this paper
• Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics.

  1999cited by this paper
• Contribution of Nitric Oxide Synthases 1, 2, and 3 to Airway Hyperresponsiveness and Inflammation in a Murine Model of Asthma

  1999cited by this paper
• NO in exhaled air is correlated with markers of eosinophilic airway inflammation in corticosteroid-dependent childhood asthma.

  1999cited by this paper
• Spirometric reference values from a sample of the general U.S. population.

  1999cited by this paper
• Expired nitric oxide after bronchoprovocation and repeated spirometry in patients with asthma.

  1998cited by this paper
• Nitric oxide synthesis in the lung. Regulation by oxygen through a kinetic mechanism.

  1998cited by this paper
• Exhaled nitric oxide correlates with airway hyperresponsiveness in steroid-naive patients with mild asthma.

  1998cited by this paper
• Bronchodilator S-nitrosothiol deficiency in asthmatic respiratory failure.

  1998cited by this paper
• Elevated nitric oxide concentrations in isolated lower airway gas of asthmatic subjects.

  1996cited by this paper
• Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients.

  1996cited by this paper
• Expired nitric oxide levels during treatment of acute asthma.

  1995cited by this paper
• Standardization of Spirometry, 1994 Update. American Thoracic Society.

  1995cited by this paper
• Reference values for residual volume, functional residual capacity and total lung capacity. ATS Workshop on Lung Volume Measurements. Official Statement of The European Respiratory Society.

  1995cited by this paper
• Increased nitric oxide in exhaled air of asthmatic patients.

  1994cited by this paper
• Single-breath nitric oxide measurements in asthmatic patients and smokers.

  1994cited by this paper
• Nitric oxide synthase in human and rat lung: immunocytochemical and histochemical localization.

  1993cited by this paper
• Enhanced superoxide production by alveolar macrophages and air-space cells, airway inflammation, and alveolar macrophage density changes after segmental antigen bronchoprovocation in allergic subjects.

  1992cited by this paper
• Lung function testing: selection of reference values and interpretative strategies.

  1992cited by this paper
• Lung function testing: selection of reference values and interpretative strategies. American Thoracic Society.

  1991cited by this paper
• Changes in total lung capacity during acute spontaneous asthma.

  1990cited by this paper
• Standardization of spirometry.

  1987cited by this paper
• The static elastic properties of the lungs in asthma.

  1968cited by this paper
• Elastic recoil of the lungs in chronic asthmatic patients before and after therapy.

  1967cited by this paper
• Storm van 's Gravesande.

  year unknowncited by this paper

• Severe asthma beyond bronchodilators: Emerging therapeutic approaches.

  2025cites this paper
• Role of precision medicine on different endotypes of asthma

  2025cites this paper
• Respiratory failure in a patient with exhaled nitric oxide >300 ppb and subsequent response to dupilumab

  2024cites this paper
• The burden of severe asthma in sub-Saharan Africa: Findings from the African Severe Asthma Project

  2024cites this paper
• Mitochondrial DNA Copy Number Variation in Asthma Risk, Severity, and Exacerbations.

  2024cites this paper
• fMRI BOLD responses to film stimuli and their association with exhaled nitric oxide in asthma and health.

  2024cites this paper
• Dupilumab reduces exacerbations independent of changes in biomarkers in moderate-to-severe asthma.

  2024cites this paper
• Mitochondrial DNA Copy Number Variation in Asthma Risk, Severity, and Exacerbations

  2023cites this paper
• Role of club cell 16‐kDa secretory protein in asthmatic airways

  2023cites this paper
• Association of nitric oxide synthase gene polymorphism with asthma: A systematic review and meta‐analysis

  2023cites this paper
• International consensus statement on allergy and rhinology: Allergic rhinitis – 2023

  2023cites this paper
• New insights into the pathophysiology and therapeutic targets of asthma and comorbid chronic rhinosinusitis with or without nasal polyposis

  2023cites this paper
• Diagnostic role of fractional exhaled nitric oxide in pediatric eosinophilic esophagitis, relationship with gastric and duodenal eosinophils

  2023cites this paper
• Clinical significance of exhaled nitric oxide, nasal nitric oxide, peripheral blood eosinophiles as markers of airway inflammation in bronchial asthma and allergic rhinitis

  2023cites this paper
• Bronchial smooth muscle cell in asthma: where does it fit?

  2022cites this paper
• Predictors of Low and High Exhaled Nitric Oxide Values in Asthma: A Real-World Study

  2022cites this paper
• Clinically relevant effects of Mindfulness-Based Stress Reduction in individuals with asthma

  2022cites this paper
• Asthma with Fixed Airflow Obstruction: From Fixed to Personalized Approach

  2022cites this paper
• Identifying asthma patients at high risk of exacerbation in a routine visit: A machine learning model.

  2022cites this paper
• Biomarkers in severe asthma: Identifying the treatable trait

  2022cites this paper
• Fraction of exhaled nitric oxide is associated with disease burden in the German Asthma Net severe asthma cohort

  2022cites this paper
• Comparison between clinical trials and real-world evidence studies on biologics for severe asthma

  2022cites this paper
• Exhaled nitric oxide in asthma: from diagnosis to management

  2022cites this paper
• Allergic Asthma in the Era of Personalized Medicine

  2022cites this paper
• Association of increased basic salivary proline‐rich protein 1 levels in induced sputum with type 2‐high asthma

  2022cites this paper
• Discerning asthma endotypes through comorbidity mapping

  2022cites this paper
• Use of FeNO to predict anti-IL-5 and IL-5R biologics efficacy in a real-world cohort of adults with severe eosinophilic asthma

  2022influential citation
• Treatment Resistance in Severe Asthma Patients With a Combination of High Fraction of Exhaled Nitric Oxide and Low Blood Eosinophil Counts

  2022cites this paper
• Phenotyping, Precision Medicine, and Asthma.

  2022cites this paper
• Clinical potential of eosinophil-derived neurotoxin in asthma management.

  2022cites this paper
• Effects of PM2.5 and temperature on the incidence of severe asthma in adults and the elderly in Shanghai, China: A retrospective study

  2022cites this paper
• [Markers of severity and predictors of response to treatment in severe asthma].

  2022cites this paper
• Airway Thiol-NO Adducts as Determinants of Exhaled NO

  2021cites this paper
• A Preliminary Report on the Correlation Between Nasal Function and the Different Phases of the Nasal Cycle

  2021cites this paper
• Increasing utility of FeNO as a biomarker of type-2 inflammation in severe asthma.

  2021cites this paper
• Response to Parenteral Triamcinolone in Severe Asthma: A Useful Induced Phenotype for Clinicians?

  2021cites this paper
• Understanding the key issues in the treatment of uncontrolled persistent asthma with type 2 inflammation

  2021cites this paper
• An update on the diagnostic biomarkers for asthma

  2021cites this paper
• Real Time Breath Analysis Using Portable Gas Chromatography for Adult Asthma Phenotypes

  2021cites this paper
• The correlation between FeNO and nNO in allergic rhinitis and bronchial asthma

  2021cites this paper
• Sputum mast cell/basophil gene expression relates to inflammatory and clinical features of severe asthma.

  2021cites this paper
• EARLY DIAGNOSTICS OF PULMONARY HEMODYNAMIC DISORDERS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND EFFECTS OF COMPLEX THERAPY

  2021cites this paper
• Biomarkers for Severe Asthma: Lessons From Longitudinal Cohort Studies

  2021cites this paper
• Asthma in the Precision Medicine Era: Biologics and Probiotics

  2021cites this paper
• Performance of fractional exhaled nitric oxide in predicting response to inhaled corticosteroids in chronic cough: a meta-analysis

  2021cites this paper
• RNA‐seq–based profiling of extracellular vesicles in plasma reveals a potential role of miR‐122‐5p in asthma

  2020cites this paper
• Clinical application of nasal nitric oxide measurement in allergic rhinitis: A systematic review and meta-analysis.

  2020cites this paper
• Efficacy and safety of inhaled nebulized sodium nitrite in asthmatic patients.

  2020cites this paper
• Blood eosinophil count combined with asthma history could predict chronic rhinosinusitis with nasal polyp recurrence

  2020cites this paper
• Asthma and fixed airflow obstruction: Long‐term trajectories suggest distinct endotypes

  2020cites this paper
• Exhaled nitric oxide as a clinical biomarker for choosing biologics for severe asthma treatment.

  2020cites this paper
• Monoclonal Antibody Therapy in Childhood Asthma

  2020cites this paper
• High fractional exhaled nitric oxide levels may predict short‐term worsening of respiratory oscillometry in asthma

  2020cites this paper
• Serum Eosinophil-derived Neurotoxin Better Reflect Asthma Control Status than Blood Eosinophil Counts.

  2020cites this paper
• Physiological tests of small airways function in diagnosing asthma: a systematic review

  2020cites this paper
• Allergic Endotypes and Phenotypes of Asthma.

  2020cites this paper
• Clinical utility of fractional exhaled nitric oxide in severe asthma management

  2020cites this paper
• New Therapies for Emerging Endotypes of Asthma.

  2020cites this paper
• Nasal Nitric Oxide in Chronic Rhinosinusitis with or without Nasal Polyps: A Systematic Review with Meta-Analysis

  2020cites this paper
• Small airway inflammation is associated with residual airway hyperresponsiveness in Th2-high asthma

  2020cites this paper
• The effects of oral corticosteroids on lung function, type-2 biomarkers and patient-reported outcomes in stable asthma: A systematic review and meta-analysis.

  2020cites this paper
• An official JRS statement: The principles of fractional exhaled nitric oxide (FeNO) measurement and interpretation of the results in clinical practice.

  2020cites this paper
• Role of Type2 Inflammatory Biomarkers in Chronic Obstructive Pulmonary Disease

  2020cites this paper
• Phenotypes of Chronic Diseases of the Airways: Towards Multidimensional Data -Driven Profiling

  2019influential citation
• Association of elevated fractional exhaled nitric oxide concentration and blood eosinophil count with severe asthma exacerbations

  2019cites this paper
• Application of structured statistical analyses to identify a biomarker predictive of enhanced tralokinumab efficacy in phase III clinical trials for severe, uncontrolled asthma

  2019cites this paper
• Fractional Exhaled Nitric Oxide Testing: Diagnostic Utility in Asthma, Chronic Obstructive Pulmonary Disease, or Asthma-chronic Obstructive Pulmonary Disease Overlap Syndrome

  2019cites this paper
• Asthma and Corticosteroid Responses in Childhood and Adult Asthma.

  2019cites this paper
• Acute Severe Asthma in Adolescent and Adult Patients: Current Perspectives on Assessment and Management

  2019cites this paper
• Fracción exhalada de óxido nítrico. Recomendaciones clínicas y procedimiento

  2019cites this paper
• A sputum 6-gene signature predicts future exacerbations of poorly controlled asthma.

  2019cites this paper
• Phenotypes favoring fractional exhaled nitric oxide discordance vs guideline-based uncontrolled asthma.

  2019cites this paper
• Exhaled nitric oxide predicts loss of asthma control in children after inhaled corticosteroids withdrawal

  2019cites this paper
• Serum levels of IL-5, IL-6, IL-8, IL-13 and IL-17A in pre-defined groups of adult patients with moderate and severe bronchial asthma.

  2019cites this paper
• Combined Assessment of Serum Periostin and YKL-40 May Identify Asthma-COPD Overlap.

  2019cites this paper
• Sorting Out Nonadherence and Airway Inflammation in Treatment Escalation for Severe Asthma.

  2019cites this paper
• Nasal Nitric Oxide Is Correlated With Nasal Patency and Nasal Symptoms

  2019cites this paper
• Exhaled Nitric Oxide in the Management of Respiratory Disorders

  2019cites this paper
• Severe Asthma

  2019cites this paper
• Remotely Monitored Therapy and Nitric Oxide Suppression Identifies Nonadherence in Severe Asthma

  2019cites this paper
• Practical Considerations in the Management of Eosinophilic Asthma

  2019cites this paper
• Leveraging genomics to uncover the genetic, environmental and age-related factors leading to asthma

  2019cites this paper
• A phase 2 study to evaluate the safety, efficacy and pharmacokinetics of DP2 antagonist GB001 and to explore biomarkers of airway inflammation in mild‐to‐moderate asthma

  2019cites this paper
• Toward clinically applicable biomarkers for asthma: An EAACI position paper

  2019cites this paper
• Roles of Periostin in Asthma.

  2019cites this paper
• Title Utility of serum periostin in combination with exhaled nitricoxide in the management of asthma

  2019cites this paper
• Three Major Efforts to Phenotype Asthma: Severe Asthma Research Program, Asthma Disease Endotyping for Personalized Therapeutics, and Unbiased Biomarkers for the Prediction of Respiratory Disease Outcome.

  2019cites this paper
• Having concomitant asthma phenotypes is common and independently relates to poor lung function in NHANES 2007–2012

  2018cites this paper
• Asthma Over the Age of 65: All's Well That Ends Well.

  2018cites this paper
• Biomarkers related to respiratory symptoms and lung function in adults with asthma

  2018cites this paper
• Biomarkers for severe allergic asthma in children: could they be useful to guide disease control and use of omalizumab?

  2018cites this paper
• Severe Asthma: Updated Therapy Approach Based on Phenotype and Biomarker

  2018cites this paper
• Usefulness of Fractional Exhaled Nitric Oxide-Guided Treatment in Patients with Asthma-Chronic Obstructive Pulmonary Disease Overlap

  2018cites this paper
• Exhaled Nitric Oxide and Exhaled Breath Condensate in the Management of Respiratory Disorders

  2018cites this paper
• Effect of the S‐nitrosoglutathione reductase inhibitor N6022 on bronchial hyperreactivity in asthma

  2018cites this paper
• Use of biomarkers to identify phenotypes and endotypes of severeasthma.

  2018cites this paper
• Nitric oxide alters hyaluronan deposition by airway smooth muscle cells

  2018cites this paper
• A Review of the Utility and Cost Effectiveness of Monitoring Fractional Exhaled Nitric Oxide (FeNO) in Asthma Management.

  2018cites this paper
• Chapter 2 Non-invasive Biomarkers in Asthma : Promises and Pitfalls

  2018cites this paper
• Epigallocatechin‐3‐gallate protects against the exacerbation of allergic eosinophilic inflammation associated with obesity in mice

  2018cites this paper